Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Two-Drug combo beat single painkiller after stomach surgery?

NCT ID NCT07768514

Symptom relief Sponsor: Seoul National University Bundang Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This trial tests whether a combination of acetaminophen and ibuprofen (Maxigesic) given through an IV can control pain better than acetaminophen alone after laparoscopic or robotic stomach cancer surgery. About 90 adults undergoing this surgery will be randomly assigned to one of the two treatments, and their pain levels will be tracked for 72 hours. The goal is to see if the combo reduces pain more effectively and safely, potentially lowering the need for stronger opioid painkillers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A fixed-dose combination of acetaminophen and ibuprofen, given intravenously as Maxigesic
What this could lead to
If effective, this could offer a better, opioid-sparing way to manage pain after gastric cancer surgery, potentially reducing opioid-related side effects.
What could go wrong
This is a small, phase 2 trial, so results may not apply broadly. The combination may not prove superior to acetaminophen alone, and there are risks like bleeding or kidney issues from ibuprofen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

90 people

The number who actually took part.

Started

Nov 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older at the time of written informed consent. * Patients scheduled to undergo laparoscopic or robotic gastrectomy for gastric cancer. * American Society of Anesthesiologists (ASA) physical status class I to III. * Patients who voluntarily decide to participate after receiving a detailed explanation of the study and provide written informed consent. Exclusion Criteria: * Patients who do not undergo laparoscopic or robotic gastrectomy. * Patients who require conversion to open surgery. * Known hypersensitivity to any component of the study medications. * Any contraindication to the use of the study medications according to the prescribing information. * Women who are pregnant or breastfeeding, or who plan to become pregnant during the study period. * Participants or their partners who do not agree to use a medically acceptable method of contraception during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastric cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stomach neoplasms

Contacts and locations

Locations

  • Seoul National University Bundang Hospital

    Seongam, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.